No Cell Line Source 1 NCI-H28 ATCC 2 NCI-H2452 ATCC 3 NCI-H2052

No Cell Line Source 1 NCI-H28 ATCC 2 NCI-H2452 ATCC 3 NCI-H2052

SUPPLEMENTARY TABLE S1. List of 19 MM cell lines used in this study. No Cell line Source 1 NCI-H28 ATCC 2 NCI-H2452 ATCC 3 NCI-H2052 ATCC 4 MSTO-211H ATCC 5 ACC-MESO-1 RBCCB 6 ACC-MESO-4 RBCCB 7 HMMME RBCCB 8 ONE58 ECACC 9 NO36 ECACC 10 LO68 ECACC 11 Mero-14 ECACC 12 Mero-25 ECACC 13 Mero-41 ECACC 14 Mero-48a ECACC 15 Mero-82 ECACC 16 Mero-83 ECACC 17 Mero-84 ECACC 18 Mero-95 ECACC 19 NCI-H226 ATCC Abbreviations: ATCC, American Type Culture Collection (Manassas,VA); RBCCB, RIKEN BioResource Center Cell Bank (Tsukuba, Japan); ECACC, European Collection of Cell Cultures (Salisbury, UK). SUPPLEMENTARY TABLE S2. Clinicopathological characteristics of 23 MM cases subjected to targeted exon sequ Asbestos Pathological Sample Tumor / normal Gender Age Smoking Surgery exposure type CT-1T Tumor and normal F 40 no yes B panpleuropneumonectomy CT-2T Tumor and normal M 51 yes no E panpleuropneumonectomy CT-3T Tumor and normal M 50 yes no B panpleuropneumonectomy CT-4T Tumor and normal M 56 yes no E panpleuropneumonectomy CT-5T Tumor and normal M 67 yes no E panpleuropneumonectomy CT-6T Tumor and normal M 60 yes yes B panpleuropneumonectomy CT-7T Tumor and normal M 48 yes no E panpleuropneumonectomy CT-9T Tumor and normal M 46 no no B panpleuropneumonectomy CT-10T Tumor and normal M 54 yes yes E panpleuropneumonectomy CT-11T Tumor and normal M 61 yes yes B panpleuropneumonectomy CT-12T Tumor and normal M 50 yes no E panpleuropneumonectomy CT-13T Tumor and normal F 56 no no E panpleuropneumonectomy CT-14T Tumor and normal M 62 yes yes E panpleuropneumonectomy CT-15T Tumor and normal M 66 no yes B panpleuropneumonectomy CT-18T Tumor and normal M 61 yes unknown S panpleuropneumonectomy CT-19T Tumor and normal M 68 yes yes B panpleuropneumonectomy CT-20T Tumor and normal M 60 yes unknown E panpleuropneumonectomy CT-21T Tumor and normal M 71 yes yes S panpleuropneumonectomy CT-22T Tumor and normal M 58 yes no E panpleuropneumonectomy CT-23T Tumor and normal F 52 yes unknown E panpleuropneumonectomy CT-24T Tumor and normal M 65 yes yes B panpleuropneumonectomy CT-33T Tumor and normal M 55 yes yes B panpleuropneumonectomy CT-46T Tumor and normal M 41 yes unknown B panpleuropneumonectomy Abbreviations: B, Biphasic; E, Epithelial; S, Sarcomatous; F, Female; M, Male. SUPPLEMENTARY TABLE S3. Hippo pathway genes sequenced in this study. Gene symbol Target HGNC ID Function Location LATS1 exon + intron HGNC:6514 LATS, large tumor suppressor, homolog 1 (Drosophila) 6q25.1 LATS2 exon + intron HGNC:6515 LATS, large tumor suppressor, homolog 2 (Drosophila) 13q11-q12 FAT4 exon HGNC:23109 FAT tumor suppressor homolog 4 (Drosophila) 4q28.1 CRB1 exon HGNC:2343 crumbs homolog 1 (Drosophila) 1q31-q32.1 CRB2 exon HGNC:18688 crumbs homolog 2 (Drosophila) 9q33.2 CRB3 exon HGNC:20237 crumbs homolog 3 (Drosophila) 19p13.3 NF2 exon HGNC:7773 neurofibromin 2 (merlin) 22q12.2 FRMD1 exon HGNC:21240 FERM domain containing 1 6q27 RASSF2 exon HGNC:9883 Ras association (RalGDS/AF-6) domain family member 2 20p13 RASSF3 exon HGNC:14271 Ras association (RalGDS/AF-6) domain family member 3 12q14.2 RASSF4 exon HGNC:20793 Ras association (RalGDS/AF-6) domain family member 4 10q11.1 RASSF5 exon HGNC:17609 Ras association (RalGDS/AF-6) domain family member 5 1q31 RASSF6 exon HGNC:20796 Ras association (RalGDS/AF-6) domain family member 6 4q21.1 KIBRA exon HGNC:29435 WW and C2 domain containing 1 5q34 MST2 exon HGNC:11406 serine/threonine kinase 3 8q22.2 MST3 exon HGNC:11403 serine/threonine kinase 24 13q31.2-q32.3 MST4 exon Gene ID: 51765 Serine/threonine protein kinase MST4 Xq26.2 MOB3C exon HGNC:29800 MOB kinase activator 3C 1p34.1 MOB4 exon HGNC:17261 MOB family member 4, phocein 2q33.1 MOB1B exon HGNC:29801 MOB kinase activator 1B 4q13.3 MOB2 exon HGNC:24904 MOB kinase activator 2 11p15.5 MOB3A exon HGNC:29802 MOB kinase activator 3A 19p13.3 MOB3B exon HGNC:23825 MOB kinase activator 3B 9p21.1 FRMD6 exon HGNC:19839 FERM domain containing 6 14q22.1 RASSF1A exon HGNC:9882 Ras association (RalGDS/AF-6) domain family member 1 3p21.3 SAV1 exon HGNC:17795 salvador homolog 1 (Drosophila) 14q13-q23 MST1 exon HGNC:7380 macrophage stimulating 1 (hepatocyte growth factor-like) 3p21 MOB1A exon HGNC:16015 MOB kinase activator 1A 2p13.1 TAZ exon HGNC:11577 tafazzin Xq28 YWHAB exon HGNC:12849 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide 20q13.1 YWHAE exon HGNC:12851 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide 17p13.3 YWHAG exon HGNC:12852 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide 7q11.23 YWHAH exon HGNC:12853 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide 22q12.1-q13.1 YWHAQ exon HGNC:12854 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide 2p25.2-p25.1 YWHAZ exon HGNC:12855 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide 8q22.3 YWHAS exon HGNC:10773 stratifin 1p36.11 TEAD1 exon HGNC:11714 TEA domain family member 1 (SV40 transcriptional enhancer factor) 11p15.4 TEAD2 exon HGNC:11715 TEA domain family member 2 19q13.3 TEAD3 exon HGNC:11716 TEA domain family member 3 6p21.2 TEAD4 exon HGNC:11717 TEA domain family member 4 12p13.3-p13.2 SUPPLEMENTARY TABLE S4. Whole-exon sequencing of 6 MM cell lines. No. Gene symbol Chr RefSeqb cDNA Amino acid Type 211H H2452 H28 MESO4 H2052 MESO1 1 EI24 11 NM_001007277 c.732_733insC p.R244fs frameshift insertion ○ ○ ○ ○ ○ ○ 2 KRTAP4-8 17 NM_031960 c.C204A p.S68R nonsynonymous SNV - - ○ - - ○ KRTAP4-8 17 NM_031960 c.2_3insA p.M1fs frameshift insertion ○ ○ ○ ○ ○ ○ 3 PRIM2 6 NM_000947 c.889_890insA p.E297fs frameshift insertion ○ ○ ○ ○ ○ ○ PRIM2 6 NM_000947 c.C916T p.R306X stopgain SNV - ○ - - - - 4 PRSS1 7 NM_002769 c.A508G p.K170E nonsynonymous SNV ○ ○ - - ○ ○ PRSS1 7 NM_002769 c.G512A p.C171Y nonsynonymous SNV ○ - - ○ - - PRSS1 7 NM_002769 c.G542A p.S181N nonsynonymous SNV ○ ○ ○ ○ ○ ○ 5 PRSS2 7 NM_002770 c.C10T p.P4S nonsynonymous SNV - - ○ ○ - - PRSS2 7 NM_002770 c.C47T p.T16I nonsynonymous SNV ○ ○ ○ ○ ○ ○ PRSS2 7 NM_002770 c.C95A p.S32Y nonsynonymous SNV ○ ○ ○ ○ ○ ○ 6 PRSS3 9 NM_001197098 c.284_285del p.95_95del frameshift deletion ○ - ○ - - - PRSS3 9 NM_001197098 c.A493G p.K165E nonsynonymous SNV - ○ - - - - PRSS3 9 NM_001197098 c.G524A p.S175N nonsynonymous SNV ○ ○ ○ ○ ○ ○ PRSS3 9 NM_001197098 c.639delT p.C213fs frameshift deletion - - ○ - - - 7 ZNF595 4 NM_182524 c.600_601insA p.Y200fs frameshift insertion ○ ○ ○ ○ ○ ○ 8 DDHD1 14 NM_001160148 c.337_338insGGCGGC p.S113delinsGGS nonframeshift insertion ○ ○ - ○ ○ ○ 9 KRT10 17 NM_000421 c.1637_1638del p.546_546del frameshift deletion - - ○ - - - KRT10 17 NM_000421 c.1468_1479del p.490_493del nonframeshift deletion ○ - - ○ ○ ○ KRT10 17 NM_000421 c.1473_1477del p.491_493del frameshift deletion - - ○ - - - 10 MLL3 7 NM_170606 c.A11405G p.D3802G nonsynonymous SNV - - - - ○ - MLL3 7 NM_170606 c.2448_2449insA p.Y816_I817delinsX stopgain SNV ○ ○ ○ - - ○ 11 OR1B1 9 NM_001004450 c.45_46insT p.L15fs frameshift insertion ○ ○ ○ ○ ○ - 12 ZAN 7 NM_173059 c.3290_3292del p.1097_1098del nonframeshift deletion - ○ - - ○ - ZAN 7 NM_003386 c.5767_5768insG p.F1923fs frameshift insertion ○ ○ - ○ - ○ 13 ALMS1 2 NM_015120 c.1570_1571insCTC p.S524delinsSP nonframeshift insertion ○ ○ - - ○ ○ 14 FZD1 7 NM_003505 c.264_265insCCG p.Q88delinsQP nonframeshift insertion ○ - ○ - ○ ○ 15 HOXD9 2 NM_014213 c.794_795insGCA p.P265delinsPQ nonframeshift insertion ○ ○ ○ ○ - - 16 KDM6B 17 NM_001080424 c.752_753insACCACC p.L251delinsLPP nonframeshift insertion - ○ - - ○ - KDM6B 17 NM_001080424 c.753_755del p.251_252del nonframeshift deletion - - - ○ - - KDM6B 17 NM_001080424 c.C1881G p.S627R nonsynonymous SNV - - ○ - - - 17 SLC9B1 4 NM_139173 c.1338_1339del p.446_447del frameshift deletion - - ○ ○ ○ ○ 18 AHNAK 11 NM_001620 c.C8897T p.P2966L nonsynonymous SNV ○ - - - - - AHNAK 11 NM_001620 c.C7225T p.P2409S nonsynonymous SNV - - - - ○ - AHNAK 11 NM_001620 c.C5565G p.I1855M nonsynonymous SNV - - - - - ○ 19 C15orf40 15 NM_001160113 c.396_397insT p.L132fs frameshift insertion ○ ○ - - - - C15orf40 15 NM_001160113 c.395delT p.L132X stopgain SNV - - - - - ○ 20 CDC27 17 NM_001114091 c.C818G p.A273G nonsynonymous SNV ○ - - ○ ○ - 21 COL6A6 3 NM_001102608 c.T3410C p.I1137T nonsynonymous SNV ○ - - - - - COL6A6 3 NM_001102608 c.C3883T p.R1295X stopgain SNV - - - - ○ - COL6A6 3 NM_001102608 c.T5542C p.F1848L nonsynonymous SNV - - ○ - - - 22 LOC388946 2 NM_001145051 c.462delG p.E154fs frameshift deletion ○ - - - ○ ○ 23 MAGEF1 3 NM_022149 c.477_478insGGA p.D159delinsED nonframeshift insertion ○ ○ ○ - - - 24 MCC 5 NM_001085377 c.64_65insGGC p.S22delinsGS nonframeshift insertion - ○ - ○ - ○ 25 MEGF9 9 NM_001080497 c.89_94del p.30_32del nonframeshift deletion - ○ ○ ○ - - 26 NBPF9 1 NM_001037675 c.116_117insAG p.K39fs frameshift insertion ○ ○ - ○ - - 27 NUDT11 X NM_018159 frameshift deletion ○ - - ○ - ○ 28 OVGP1 1 NM_002557 c.1560_1561insA p.G520fs frameshift insertion ○ - - - ○ ○ 29 RBMX X NM_002139 c.906_907insCC p.P302fs frameshift insertion ○ - - - ○ - RBMX X NM_002139 c.316_317insTT p.P106fs frameshift insertion ○ - ○ - ○ - 30 TDG 12 NM_003211 c.286_287insA p.E96fs frameshift insertion - ○ ○ ○ - - 31 ZFHX3 16 NM_001164766 c.2482_2483insCAA p.A828delinsQA nonframeshift insertion - - ○ - - - ZFHX3 16 NM_001164766 c.2476_2481del p.826_827del nonframeshift deletion - - - - - ○ ZFHX3 16 NM_006885 c.C1114G p.R372G nonsynonymous SNV - - - ○ - - 32 ABCA7 19 NM_019112 c.1180_1190del p.394_397del frameshift deletion

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    20 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us